BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37879822)

  • 21. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
    Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
    Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive and Non-invasive Ductal Carcinoma within Malignant Phyllodes Tumour with Axillary Lymph Node Metastases.
    Erdogan O; Parlakgumus A; Tas ZA; Yener K; Turan U
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):S92-S94. PubMed ID: 36210658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
    Ramzi S; Najeeb E; Coulthard J; Jenkins S
    Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
    Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
    Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sentinel lymph node examination in breast carcinoma in situ].
    Mergancová J; Mergancová J; Hrncirová I; Kerekes Z; Hácová M
    Rozhl Chir; 2011 Jul; 90(7):393-6. PubMed ID: 22026090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
    Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
    Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
    Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
    J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of occult invasion in ductal carcinoma in situ of the breast with sentinel node metastasis.
    Osako T; Iwase T; Kimura K; Horii R; Akiyama F
    Cancer Sci; 2013 Apr; 104(4):453-7. PubMed ID: 23281914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
    Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
    Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ductal carcinoma in situ-like structures in metastatic breast carcinoma.
    Kordek R
    Pathol Res Pract; 2005; 200(11-12):831-4. PubMed ID: 15792128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
    Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
    J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is Axillary Assessment of Ductal Carcinoma In Situ of the Breast Necessary in All Cases?
    Bellver G; Buch E; Ripoll F; Adrianzen M; Bermejo B; Burgues O; Julve A; Ortega J
    J Surg Res; 2022 Mar; 271():145-153. PubMed ID: 34902737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
    van la Parra RF; Ernst MF; Barneveld PC; Broekman JM; Rutten MJ; Bosscha K
    Eur J Surg Oncol; 2008 Jun; 34(6):631-5. PubMed ID: 17851019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
    Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
    Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
    Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
    Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel node mapping and ductal carcinoma in situ.
    Pollock SE; Pollock J; Nestor S; Hardin R; Ghaphery D
    Breast Cancer; 2019 Sep; 26(5):612-617. PubMed ID: 30903404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of sentinel lymph node biopsy in ductal carcinoma in situ.
    Moran CJ; Kell MR; Kerin MJ
    Eur J Surg Oncol; 2005 Dec; 31(10):1105-11. PubMed ID: 16084681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between lymph node metastasis and pathologic features of invasive micropapillary carcinoma of breast].
    Guo XJ; Chen L; Lang RG; Fan Y; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):8-12. PubMed ID: 16608641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.
    Osako T; Iwase T; Ushijima M; Horii R; Fukami Y; Kimura K; Matsuura M; Akiyama F
    Cancer Sci; 2014 May; 105(5):576-82. PubMed ID: 24533797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node biopsy for localised ductal carcinoma in situ?
    Veronesi P; Intra M; Vento AR; Naninato P; Caldarella P; Paganelli G; Viale G
    Breast; 2005 Dec; 14(6):520-2. PubMed ID: 16185871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.